Deep Track Capital »

Alumis shares owned by Deep Track Capital

Quarter-by-quarter ownership of Alumis (ALMS) shares owned by Deep Track Capital from 13F filings

Historical chart of Deep Track Capital investment in Alumis

Tip: Access up to 7 years of quarterly data

All positions including Alumis held by Deep Track Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alumis by Deep Track Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $149M 6.8M 22.03

More positions owned by Deep Track Capital

Spdr Series Trust State Street Spd Put Option (XBI)
Guardant Health (GH)
Immunovant (IMVT)
Tarsus Pharmaceuticals (TARS)
Vaxcyte (PCVX)
Structure Therapeutics Sponsored Ads (GPCR)
Axsome Therapeutics (AXSM)
Apellis Pharmaceuticals (APLS)
Ocular Therapeutix (OCUL)
Vera Therapeutics Cl A (VERA)
Alumis (ALMS)
Ionis Pharmaceuticals (IONS)
Nuvalent Inc-a (NUVL)
Alkermes SHS (ALKS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)

View all positions for Deep Track Capital

Top funds holding Alumis

AyurMaya Capital Management Company
BlackRock
Deep Track Capital
Samsara BioCapital
Foresite Capital Management V
venBio Partners
Foresite Capital Management VI
Vanguard Group
Vanguard Capital Management
Cormorant Asset Management
Nextech Invest
Saturn V Capital Management
UBS Group
Octagon Capital Advisors
MPM Oncology Impact Management

View all funds holding Alumis